Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma

Qiu yuan Xia, Qiu Rao, Liang Cheng, Qin Shen, Shan shan Shi, Li Li, Biao Liu, Jin Zhang, Yan fen Wang, Qun li Shi, Jian dong Wang, Heng hui Ma, Zhen feng Lu, Bo Yu, Ru song Zhang, Xiao jun Zhou

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aims: The aim of this study was to examine the status of Brahma (BRM), a key SWI/SNF complex subunit, in clear cell renal cell carcinomas (RCCs), and to analyse the histopathology, immunophenotype, molecular features and prognosis of the BRM-negative cases. Methods and results: We identified 19 cases of grade 4 tumours lacking BRM expression among 625 clear cell RCCs. All 19 cases exhibited features of poor differentiation: 13 showed pure poorly differentiated morphology, while six were composite tumours with an admixed typical low-grade component. Besides negative BRM expression, the immunophenotype of these cases was similar to clear cell RCC. VHL gene mutations were identified in nine of the 19 patients (47%). Chromosome 3p deletion was detected in 11 of 13 poorly differentiated RCCs and both areas of five of five composite tumours. All poorly differentiated tumour areas showed polysomy of chromosome 3. No losses or gains of chromosome 3 were observed in low-grade tumour areas of five of five composite RCCs. Conclusions: We have shown that loss of BRM expression is a common feature among poorly differentiated tumours in clear cell RCCs. We hypothesize that loss of BRM expression is involved in tumor de-differentiation in clear cell RCCs and may play an important role during tumour progression.

Original languageEnglish
Pages (from-to)847-862
Number of pages16
JournalHistopathology
Volume64
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Renal Cell Carcinoma
Neoplasms
Chromosomes, Human, Pair 3
Chromosome Deletion
Mutation
Genes

Keywords

  • BRM/SMARCA2
  • Clear cell carcinoma
  • Fluorescence in-situ hybridization
  • High-grade
  • Immunohistochemistry
  • Poorly differentiated
  • Renal cell carcinoma
  • Rhabdoid
  • SWI/SNF complex
  • Von Hippel-Lindau

ASJC Scopus subject areas

  • Histology
  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma. / Xia, Qiu yuan; Rao, Qiu; Cheng, Liang; Shen, Qin; Shi, Shan shan; Li, Li; Liu, Biao; Zhang, Jin; Wang, Yan fen; Shi, Qun li; Wang, Jian dong; Ma, Heng hui; Lu, Zhen feng; Yu, Bo; Zhang, Ru song; Zhou, Xiao jun.

In: Histopathology, Vol. 64, No. 6, 2014, p. 847-862.

Research output: Contribution to journalArticle

Xia, QY, Rao, Q, Cheng, L, Shen, Q, Shi, SS, Li, L, Liu, B, Zhang, J, Wang, YF, Shi, QL, Wang, JD, Ma, HH, Lu, ZF, Yu, B, Zhang, RS & Zhou, XJ 2014, 'Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma', Histopathology, vol. 64, no. 6, pp. 847-862. https://doi.org/10.1111/his.12334
Xia, Qiu yuan ; Rao, Qiu ; Cheng, Liang ; Shen, Qin ; Shi, Shan shan ; Li, Li ; Liu, Biao ; Zhang, Jin ; Wang, Yan fen ; Shi, Qun li ; Wang, Jian dong ; Ma, Heng hui ; Lu, Zhen feng ; Yu, Bo ; Zhang, Ru song ; Zhou, Xiao jun. / Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma. In: Histopathology. 2014 ; Vol. 64, No. 6. pp. 847-862.
@article{08b74745e46c490f8a082b5682b2113a,
title = "Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma",
abstract = "Aims: The aim of this study was to examine the status of Brahma (BRM), a key SWI/SNF complex subunit, in clear cell renal cell carcinomas (RCCs), and to analyse the histopathology, immunophenotype, molecular features and prognosis of the BRM-negative cases. Methods and results: We identified 19 cases of grade 4 tumours lacking BRM expression among 625 clear cell RCCs. All 19 cases exhibited features of poor differentiation: 13 showed pure poorly differentiated morphology, while six were composite tumours with an admixed typical low-grade component. Besides negative BRM expression, the immunophenotype of these cases was similar to clear cell RCC. VHL gene mutations were identified in nine of the 19 patients (47{\%}). Chromosome 3p deletion was detected in 11 of 13 poorly differentiated RCCs and both areas of five of five composite tumours. All poorly differentiated tumour areas showed polysomy of chromosome 3. No losses or gains of chromosome 3 were observed in low-grade tumour areas of five of five composite RCCs. Conclusions: We have shown that loss of BRM expression is a common feature among poorly differentiated tumours in clear cell RCCs. We hypothesize that loss of BRM expression is involved in tumor de-differentiation in clear cell RCCs and may play an important role during tumour progression.",
keywords = "BRM/SMARCA2, Clear cell carcinoma, Fluorescence in-situ hybridization, High-grade, Immunohistochemistry, Poorly differentiated, Renal cell carcinoma, Rhabdoid, SWI/SNF complex, Von Hippel-Lindau",
author = "Xia, {Qiu yuan} and Qiu Rao and Liang Cheng and Qin Shen and Shi, {Shan shan} and Li Li and Biao Liu and Jin Zhang and Wang, {Yan fen} and Shi, {Qun li} and Wang, {Jian dong} and Ma, {Heng hui} and Lu, {Zhen feng} and Bo Yu and Zhang, {Ru song} and Zhou, {Xiao jun}",
year = "2014",
doi = "10.1111/his.12334",
language = "English",
volume = "64",
pages = "847--862",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma

AU - Xia, Qiu yuan

AU - Rao, Qiu

AU - Cheng, Liang

AU - Shen, Qin

AU - Shi, Shan shan

AU - Li, Li

AU - Liu, Biao

AU - Zhang, Jin

AU - Wang, Yan fen

AU - Shi, Qun li

AU - Wang, Jian dong

AU - Ma, Heng hui

AU - Lu, Zhen feng

AU - Yu, Bo

AU - Zhang, Ru song

AU - Zhou, Xiao jun

PY - 2014

Y1 - 2014

N2 - Aims: The aim of this study was to examine the status of Brahma (BRM), a key SWI/SNF complex subunit, in clear cell renal cell carcinomas (RCCs), and to analyse the histopathology, immunophenotype, molecular features and prognosis of the BRM-negative cases. Methods and results: We identified 19 cases of grade 4 tumours lacking BRM expression among 625 clear cell RCCs. All 19 cases exhibited features of poor differentiation: 13 showed pure poorly differentiated morphology, while six were composite tumours with an admixed typical low-grade component. Besides negative BRM expression, the immunophenotype of these cases was similar to clear cell RCC. VHL gene mutations were identified in nine of the 19 patients (47%). Chromosome 3p deletion was detected in 11 of 13 poorly differentiated RCCs and both areas of five of five composite tumours. All poorly differentiated tumour areas showed polysomy of chromosome 3. No losses or gains of chromosome 3 were observed in low-grade tumour areas of five of five composite RCCs. Conclusions: We have shown that loss of BRM expression is a common feature among poorly differentiated tumours in clear cell RCCs. We hypothesize that loss of BRM expression is involved in tumor de-differentiation in clear cell RCCs and may play an important role during tumour progression.

AB - Aims: The aim of this study was to examine the status of Brahma (BRM), a key SWI/SNF complex subunit, in clear cell renal cell carcinomas (RCCs), and to analyse the histopathology, immunophenotype, molecular features and prognosis of the BRM-negative cases. Methods and results: We identified 19 cases of grade 4 tumours lacking BRM expression among 625 clear cell RCCs. All 19 cases exhibited features of poor differentiation: 13 showed pure poorly differentiated morphology, while six were composite tumours with an admixed typical low-grade component. Besides negative BRM expression, the immunophenotype of these cases was similar to clear cell RCC. VHL gene mutations were identified in nine of the 19 patients (47%). Chromosome 3p deletion was detected in 11 of 13 poorly differentiated RCCs and both areas of five of five composite tumours. All poorly differentiated tumour areas showed polysomy of chromosome 3. No losses or gains of chromosome 3 were observed in low-grade tumour areas of five of five composite RCCs. Conclusions: We have shown that loss of BRM expression is a common feature among poorly differentiated tumours in clear cell RCCs. We hypothesize that loss of BRM expression is involved in tumor de-differentiation in clear cell RCCs and may play an important role during tumour progression.

KW - BRM/SMARCA2

KW - Clear cell carcinoma

KW - Fluorescence in-situ hybridization

KW - High-grade

KW - Immunohistochemistry

KW - Poorly differentiated

KW - Renal cell carcinoma

KW - Rhabdoid

KW - SWI/SNF complex

KW - Von Hippel-Lindau

UR - http://www.scopus.com/inward/record.url?scp=84898057938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898057938&partnerID=8YFLogxK

U2 - 10.1111/his.12334

DO - 10.1111/his.12334

M3 - Article

VL - 64

SP - 847

EP - 862

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 6

ER -